Retrospective evaluation of RET biomarker status and outcome to vandetanib in four phase III randomized NSCLC trials.
Adam Platt
Employment or Leadership Position - AstraZeneca
Paul Elvin
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Research Funding - AstraZeneca
John Morten
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Qunsheng Ji
Employment or Leadership Position - AstraZeneca
Emma Donald
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Chris Womack
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Xinying Su
Employment or Leadership Position - AstraZeneca
Li Zheng
Employment or Leadership Position - AstraZeneca
Amanda Gladwin
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
James Robert Vasselli
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Jin Soo Lee
Research Funding - AstraZeneca
Richard H. De Boer
Consultant or Advisory Role - AstraZeneca
Honoraria - AstraZeneca
Research Funding - AstraZeneca
Roy S. Herbst
No relevant relationships to disclose